| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.52 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.54 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |